News
06-27-2008, 09:20 AM
Bionovo Inc. (Nasdaq: BNVI) announced results on the role of estrogen regulatory elements important in developing drugs for breast cancer and osteoporosis. The data, which were presented at the Endocrine Society's 90th Annual Meeting, showed that the new regulatory elements are essential for the differentiation of the estrogenic pharmacological activity exerted by different compounds.
More... (http://www.medicalnewstoday.com/articles/111480.php)
More... (http://www.medicalnewstoday.com/articles/111480.php)